Polyak SJ, Mac Ardle S, Liu SL, Sullivan DG, Chung M, Hofgartner WT, Carithers RL, Mac Mahon B, Mullins JI, Corey L & Gretch DR (1998) Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection
Lets talk: The full results from Lillys ATTAIN-1 trial were published in the NEJM this week, evaluating orforglipron for obesity treatment
A 9-item PSA-Lung instrument was evaluated, at per-surgery, postoperation daily until discharge, and twice a week for 4 weeks after discharge
You may not notice drastic changes right away, but you could start experiencing some of the early benefits, like reduced hunger
Disclaimer : All information is for educational and research purposes only
Data are mixed on whether it can reduce risk of gastric and esophageal cancers (5) (6) (7)